Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact.
| Publicado en: | Pharmaceutical Technology Europe Vol. 30; no. 1; pp. 28 - 35 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jan2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127579443&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 127579443 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Jan2018 vid: 30 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 127579443 127579443 ppf: 28 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Removing Subjectivity from the Assessment of Critical Process Parameters and Their Impact. aug: au: Fasheng Li Evans, Brad Fangfang Liu Jingnan Zhang Ke Wang Aili Cheng affil: Director, Pfizer’s department of pharmaceutical science and manufacturing statistics. sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|